[{"Assets_0_Q2_USD":139893000.0,"CommonStockSharesOutstanding_0_Q2_shares":34059214.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":22552000.0,"NetIncomeLoss_1_Q2_USD":-17194000.0,"NetIncomeLoss_2_Q2_USD":-33961000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":33315809.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":33000487.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":33315809.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":33000487.0,"StockholdersEquity_0_Q2_USD":73076000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":2874000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":2874000.0,"Ticker":"CARA","CIK":"1346830","name":"CARA THERAPEUTICS, INC.","OfficialName":"Cara Therapeutics Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"703167627.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180807"}]